BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31820411)

  • 1. Assessing the downstream value of first-line cardiac positron emission tomography (PET) imaging using real world Medicare fee-for-service claims data.
    Ma Q; Sridhar G; Power T; Agiro A
    J Nucl Cardiol; 2021 Oct; 28(5):2126-2137. PubMed ID: 31820411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in High- and Low-Value Cardiovascular Diagnostic Testing in Fee-for-Service Medicare, 2000-2016.
    Kini V; Viragh T; Magid D; Masoudi FA; Moghtaderi A; Black B
    JAMA Netw Open; 2019 Oct; 2(10):e1913070. PubMed ID: 31603486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries.
    Shreibati JB; Baker LC; Hlatky MA
    JAMA; 2011 Nov; 306(19):2128-36. PubMed ID: 22089720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
    Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
    JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(12):1-38. PubMed ID: 23074389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve.
    Danad I; Raijmakers PG; Driessen RS; Leipsic J; Raju R; Naoum C; Knuuti J; Mäki M; Underwood RS; Min JK; Elmore K; Stuijfzand WJ; van Royen N; Tulevski II; Somsen AG; Huisman MC; van Lingen AA; Heymans MW; van de Ven PM; van Kuijk C; Lammertsma AA; van Rossum AC; Knaapen P
    JAMA Cardiol; 2017 Oct; 2(10):1100-1107. PubMed ID: 28813561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018.
    Mafi JN; Reid RO; Baseman LH; Hickey S; Totten M; Agniel D; Fendrick AM; Sarkisian C; Damberg CL
    JAMA Netw Open; 2021 Feb; 4(2):e2037328. PubMed ID: 33591365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.
    Maddahi J; Lazewatsky J; Udelson JE; Berman DS; Beanlands RSB; Heller GV; Bateman TM; Knuuti J; Orlandi C
    J Am Coll Cardiol; 2020 Jul; 76(4):391-401. PubMed ID: 32703509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.
    Knight S; Min DB; Le VT; Meredith KG; Dhar R; Biswas S; Jensen KR; Mason SM; Ethington JD; Lappe DL; Muhlestein JB; Anderson JL; Knowlton KU
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.
    Amjad H; Carmichael D; Austin AM; Chang CH; Bynum JP
    JAMA Intern Med; 2016 Sep; 176(9):1371-8. PubMed ID: 27454945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and key differences between patient populations receiving imaging modalities for coronary artery disease diagnosis in the US.
    Pelletier-Galarneau M; Vandenbroucke E; Lu M; Li O
    BMC Cardiovasc Disord; 2023 May; 23(1):251. PubMed ID: 37189049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.
    Jaarsma C; Leiner T; Bekkers SC; Crijns HJ; Wildberger JE; Nagel E; Nelemans PJ; Schalla S
    J Am Coll Cardiol; 2012 May; 59(19):1719-28. PubMed ID: 22554604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(9):1-61. PubMed ID: 23074412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
    Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
    Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries.
    Jennings LA; Laffan AM; Schlissel AC; Colligan E; Tan Z; Wenger NS; Reuben DB
    JAMA Intern Med; 2019 Feb; 179(2):161-166. PubMed ID: 30575846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.